Options for Transplant Ineligible Patients in Multiple Myeloma

KarMMA-2 cohort 2b update: ide-cel for transplant-ineligible patients with high-risk myelomaПодробнее

Discussing Treatment Algorithm for Newly Diagnosed Multiple Myeloma with Dr. Caitlin CostelloПодробнее

Isa-VRd vs VRd for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (IMROZ)Подробнее

Multiple Myeloma - 2023 Best of Hematology ConferenceПодробнее

The Evolution of Systemic Therapy for Newly Diagnosed Multiple Myeloma, Dana-Farber Cancer InstituteПодробнее

Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-FarberПодробнее

Should You Get a Stem Cell Transplant for Multiple Myeloma? What Patients Need to Know!Подробнее

Multiple Myeloma: Should I Get Vaccinated? | The Patient StoryПодробнее

Quadruplet regimens for patients with transplant-ineligible multiple myelomaПодробнее

Evolving treatment options in NDMM: transplant-eligible and transplant-ineligible patientsПодробнее

Treatment approaches for transplant-eligible and transplant-ineligbile myeloma patientsПодробнее

Optimal treatment strategies for multiple myelomaПодробнее

Treatment options for transplant-ineligble myeloma patients: the promise of combination therapiesПодробнее

Multiple Myeloma heme malignancies BCOP 2021Подробнее

Newest Immunotherapies for Blood Cancer! What to Know about Bispecifics & CAR T-Cell TherapyПодробнее

Treatment options for relapsed young myelomaПодробнее

Management of newly diagnosed patients with multiple myeloma not eligible for transplantationПодробнее

Top Doctor & Patient Talk Game Changing Cancer Treatments: How Close is a Cure? (Multiple Myeloma)Подробнее

Challenges faced when treating transplant-ineligible patients with myelomaПодробнее

Frontline Therapy in Myeloma for Transplant Ineligible PatientsПодробнее